Talreja et al. found the evidence for the contribution of RIPK2 to the pathology of sarcoidosis, a multisystem granulomatous disease that primarily occurs in the lungs (Talreja et al., 2016). The gene discussed is RIPK2; the disease is sarcoidosis.